Polish physicians attitudes towards antibiotic prescription and antimicrobial resistance

• Autorzy: Mazinska B. , Hryniewicz W.
• Języki publikacji: EN

Abstrakty

EN

Antimicrobial resistance has been one of the biggest global current issues in medicine and public health. Overuse and imprudent use of antimicrobial agents are recognized as one of the leading causes of antibiotic resistance. The aim of this study was to analyze the attitudesof Polish physicians practicing at the community level towards antibiotics and antimicrobial resistance. The majority of physicians taking part in the survey believed that Polish people overuse antibiotics (98%). Most physicians (91%) considered that antimicrobial resistance is a major problem at present. The majority of physicians indicated the reasons for prescribing the antibiotic are related to health factors, such as optimal recovery (best effectiveness, least side effects) (80%), latest therapeutic guidelines (70%) and microbiological/epidemiological factors (63%). Knowledge of the National Recommendations for the management of Community-Acquired Respiratory Tract Infections 2010(NR-CA-RTI) developed within National Programme for Protection of Antibiotics was declared by 84% of respondents. Among those who are aware of the NR-CA-RTI, the majority follow them in their daily practice (91%). Among physicians, 62% are not familiar with the Centor/McIsaac scores used to differentiate bacterial and viral infections in patients presenting with a sore throat. Among physicians familiar with the scores, 90% use them in their daily practice. Rapid microbiological detection methods for Group A beta-hemolytic streptococcal pharyngitis are used only by 20% of respondents. Almost all of physicians declared readiness to use these tests. Main sources of information on antibiotics prescribing originate from Polish medical journals, scientific conferences organized by medical societies, pharmaceutical companies.

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2017
• Tom: 66
• Numer: 3
• Opis fizyczny: p.309-319,fig.,ref.

Twórcy

autor

Mazinska B.

• Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland

autor

Hryniewicz W.

• Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland

Bibliografia

• Ashworth M., P. White, H. Jongsma, P. Schofield and D. Armstrong. 2016. Antibiotic prescribing and patient satisfaction inprimary care in England: cross-sectional analysis of national patient survey data and prescribing data. Br. J. Gen. Pract. 2016. 66:40–46.
• Bjorkman I., J. Berg, N. Viberg and C. Stalsby Lundborg. 2013. Awareness of antibiotic resistance and antibiotic prescribing in UTI treatment: a qualitative study among primary care physicians in Sweden. Scand. J. Prim. Health Care 31: 50–55.
• Bronzwaer S.L., O. Cars, U. Buchholz, S. Mölstad, W. Goettsch, I.K. Veldhuijzen, J.L. Kool, M.J. Sprenger and J.E. Degener. 2002. An European study on the relationship between antimicrobial use and antimicrobial resistance. European Antimicrobial Resistance Surveillance System. Emerg. Infect. Dis. 8: 278–282.
• Caamano F., A. Figueiras and J.J. Gestal-Otero. 2002. Influence of commercial information on prescription quantity in primary care. Eur. J. Public Health 12: 187–191.
• Chahwakilian P., B. Huttner, B. Schlemmer and S. Harbarth. 2011. Impact of the French campaign to reduce inappropriate ambulatory antibiotic use on the prescription and consultation rates for respiratory tract infections. J. Antimicrob. Chemother. 66: 2872–2879.
• Chaintarli K., S.M. Ingle, A. Bhattacharya, D. Ashiru-Oredope, I. Oliver and M. Gobin. 2016. Impact of a United Kingdom-wide campaign to tackle antimicrobial resistance on self-reported knowledge and behaviour change. BMC Public Health 16: 393.
• Dyar O.J., P. Howard, D. Nathwani, C. Pulcini; ESGAP (theESCMID [European Society of Clinical Microbiology, Infectious Diseases] Study Group for Antibiotic Policies). 2013. Knowledge, attitudes, and beliefs of French medical students about antibiotic prescribing and resistance. Med. Mal. Infect. 43: 423–430.
• Dyar O.J., C. Pulcini, P. Howard, D. Nathwani, ESGAP (ESCMIDStudy Group for Antibiotic Policies). 2014. European medical students: a first multicentre study of knowledge, attitudes and perceptions of antibiotic prescribing and antibiotic resistance. J. Antimicrob. Chemother. 69: 842–846.
• Earnshaw S., G. Mancarella, A. Mendez, B. Todorova, A.P. Magiorakos, E. Possenti, M. Stryk, S. Gilbro, H. Goossens, B. Albiger,D.L. Monnet and others. 2014. European Antibiotic Awareness Day: a five-year perspective of Europe-wide actions to promote prudent use of antibiotics. Euro Surveill. 19: 20928.
• European Centre for Disease Prevention and Control (ECDC). 2016. Antimicrobial consumption interactive database (ESAC-Net). Stockholm, ECDC. Available from:http://www.ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/esac-net-database/Pages/database.aspx, 2017. 05.01.
• Figueiras A., I Sastre, F. Tato, C. Rodríguez, E. Lado, F. Caamaño and J.J. Gestal-Otero. 2001. One-to-one versus group sessions to improve prescription in primary care: a pragmatic randomized controlled trial. Med. Care 39: 158–167.
• Fine A.M., V. Nizet and K.D. Mandl. 2012. Large-scale validation of the Centor and McIsaac scores to predict group A streptococcal pharyngitis. Arch. Intern. Med. 172: 847–852.
• Giblin T.B., R.L. Sinkowitz-Cochran, P.L. Harris, S. Jacobs,K. Liberatore, M.A. Palfreyman, E.I. Harrison, D.M. Cardo and CDC Campaign to Prevent Antimicrobial Resistance Team. 2004. Clinicians’ perceptions of the problem of antimicrobial resistance in health care facilities. Arch. Intern. Med. 164: 1662–1668.
• Grossman Z., S. del Torso, A. Hadjipanayis, D. van Esso, A. Drabik and M. Sharland. 2012. Antibiotic prescribing for upper respiratory infections: European primary paediatricians’ knowledge, attitudes and practice. Acta Paediatrica 101: 935–940.
• Hryniewicz W., T.Ozorowski, A. Radzikowski, T.M. Zielonka,P. Albrecht, W. Lukas, E. Niżankowska-Mogielnicka, J. Kozileski, P. Grzesiowski, J. Meszaros and others. 2009. National Recommendations on the Management of Community-Acquired Respiratory Tract Infections (in Polish). National Medicines Institute, Warsaw (update 2016) http://www.antybiotyki.edu.pl/s, 2017.05.01.
• Huttner B., H. Goossens, T. Verheij, S. Harbarth and CHAMP consortium. 2010. Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect. Dis. 10: 17–31.
• Lundkvist J., I. Akerlind, L. Borgquist and S. Molstad. 2002. The more time spent on listening, the less time spent on prescribing antibiotics in general practice. Fam. Pract. 19: 638–640.
• McGettigan P., J. Golden, J. Fryer, R. Chan and J. Feely. 2001. Prescribers prefer people: The sources of information used by doctors for prescribing suggest that the medium is more important than the message. Br. J. Clin. Pharmacol. 51: 184–189.
• Milos V., T. Westerlund, P. Midlöv and E.L. Strandberg. 2014. Swedish general practitioners’ attitudes towards treatment guidelines – a qualitative study. BMC Fam. Pract. 15: 199.
• Minen M.T., D. Duquaine, M.A. Marx and D. Weiss. 2010. A survey of knowledge, attitudes, and beliefs of medical students concerning antimicrobial use and resistance. Microb. Drug Resist. 16: 285–289.
• Michel-Lepage A., B. Ventelou, P. Verger and C. Pulcini. 2014. Factors associated with the use of rapid antigen diagnostic tests in children presenting with acute pharyngitis among French general practitioners. Eur. J. Clin. Microbiol. Infect. Dis. 33: 723–728.
• Napolitano F., M.T. Izzo, G. di Giuseppe and I.F. Angelillo. 2013. Public knowledge, attitudes, and experience regarding the use of antibiotics in Italy. PLoS One 8: e84177.
• Ong S., J. Nakase, G.J. Moran, D.J. Karras, M.J. Kuehnert,D.A. Talan and EMERGEncy ID NET Study Group. 2007. Antibiotic use for emergency department patients with upper respiratory infections: prescribing practices, patient expectations, and patient satisfaction. Ann. Emerg. Med. 50: 213–220.
• Palla H.A., R.A. Khan, A.H. Giliani and F. Marra. 2012. Over prescription of antibiotics for adult pharyngitis is prevalent in developing countries but can be reduced using McIsaac modification of Centor scores: a cross-sectional study. BMC Pulm. Med. 12: 70.
• Petursson P. 2005. GPs’ reasons for “non-pharmacological” prescribing of antibiotics. A phenomenological study. Scand. J. Prim. Health Care 23: 120–125.
• Pulcini C., F. Williams, N. Molinari, P. Davey and D. Nathwani. 2011. Junior doctors’ knowledge and perceptions of antibiotic resistance and prescribing: a survey in France and Scotland. Clin. Microbiol. Infect. 17: 80–87.
• Shapiro E. 2002. Injudicious antibiotic use: an unforeseen consequence of the emphasis on patient satisfaction? Clin. Ther. 24: 197–204.
• Simpson S.A., F. Wood and C.C. Butler. 2007. General practitioners’ perceptions of antimicrobial resistance: a qualitative study.J. Antimicrob. Chemother. 59: 292–296.
• Stefaniuk E., K. Bosacka, M. Wanke-Rytt and W. Hryniewicz. 2017. The use of rapid test QuikRead go® Strep A in bacterial pharyngotonsillitis diagnosing and therapeutic decisions. Eur. J. Clin. Microbiol. Infect. Dis. doi:10.1007/s10096-017-2986-8.
• Strandberg E.L., A. Brorsson, C. Hagstam, M. Troein andK. Hedin. 2013. “I’m Dr Jekyll and Mr Hyde”: are GPs’ antibiotic prescribing patterns contextually dependent? A qualitative focus group study. Scand. J. Prim. Health Care 31:158–165.
• Strumiło J., S. Chlabicz, B. Pytel-Krolczuk, L. Marcinowicz, D. Rogowska-Szadkowska and A.J. Milewska. 2016. Combined assessment of clinical and patient factors on doctors’ decisions to prescribe antibiotics. BMC Fam. Pract. 17: 63.
• TNS Opinion and Social. 2016. Special eurobarometer 445: antimicrobial resistance. Brussels, Belgium.
• Wester C.W., L. Durairaj, A.T. Evans, D.N.Schwartz, S. Husain and E. Martinez. 2002. Antibiotic resistance: a survey of physician perceptions. Arch. Intern. Med. 62: 2210–2216.
• World Health Organization (WHO). 2014. Antimicrobial resistance: global report on surveillance. WHO, Geneva.

Identyfikatory

DOI

10.5604/01.3001.0010.4856